Clinical Trial Update: Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial compared duloxetine with placebo for preventing recurrence of major depressive disorder. The study completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2009-07-17